Men's Health News

RSS

Mediterranean diet has the potential to effect progression of prostate cancer

In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.

7 Jan 2021

Resistance training provides similar relative benefits to older men and women

Men and women aged over 50 can reap similar relative benefits from resistance training, a new study led by UNSW Sydney shows.

7 Jan 2021

Males at higher risk of severe COVID-19 and mortality in Indian case study

A new US-based study by researchers at Dartmouth College, the Development Data Lab, IDFC Institute, Johns Hopkins University, and the University of Chicago shows that the infection fatality rate (IFR) could be twice as high for men compared to women and increases much less at older ages compared to high-income countries.

7 Jan 2021

COVID-19 vaccine hesitancy in UK varies significantly between population subgroups

Researchers investigating attitudes towards vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among the UK population have found that, overall, most people were willing to accept a vaccine.

5 Jan 2021

Genetic risk score can be used to determine risk of developing prostate cancer

Some racial and ethnic groups suffer relatively more often, and fare worse, from common ailments compared to others. Prostate cancer is one disease where such health disparities occur: risk for the disease is about 75 percent higher, and prostate cancer is more than twice as deadly, in Blacks compared to whites.

4 Jan 2021

$Prolactin triggers male refractory period, indicates study$

Prolactin triggers male refractory period, indicates study

If you type into a search engine - "why do men have to wait before having sex again?" - you will very quickly come across Prolactin. This little hormone is thought to be involved in hundreds of physiological processes in the body. Among them is the male post-ejaculatory refractory period. This period begins when a male ejaculates and ends when he recovers his sexual capacity.

4 Jan 2021

Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT

Prostate cancer is one of the most common cancers among men in the U.S. For many patients, hormone therapy is a treatment option.

4 Jan 2021

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.

18 Dec 2020

New prognostic tool predicts the need for ICU among COVID-19 patients

Researchers in the UK have developed a prognostic tool that accurately predicts whether patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent causes coronavirus disease 2019 (COVID-19) – will require admission to the intensive care unit (ICU), die, or survive without escalation to ICU.

17 Dec 2020

Genomic and immune indicators can help identify prostate cancer patients at high risk of lethal outcomes

Prostate cancer is one of the most common cancers among men in the United States. One in nine men will be diagnosed during his lifetime.

15 Dec 2020

Research shows fitness suffered in most individuals during COVID-19

Researchers from the University of Texas, San Antonio and UT-Health Sciences, Texas, recently attempted to fill this knowledge gap by addressing how the COVID-19 pandemic and related stay-at-home orders are changing the daily habits of individuals.

14 Dec 2020

Study explores inequalities in mental health burden of COVID-19 pandemic

Researchers in Israel have conducted a study exploring the behavioral and psychological impact of the coronavirus disease 19 (COVID-19) pandemic in an effort to understand the biological and environmental factors that may influence how individuals cope with the crisis.

10 Dec 2020

COVID-19 control measures reduce walking activities in United States

An international team of researchers has conducted a study demonstrating the effects that coronavirus disease 2019 (COVID-19) control measures have had on people’s walking patterns in the United States.

9 Dec 2020

Public willingness to take a COVID-19 vaccine around the globe: Study

The worldwide impact of the COVID-19 pandemic led to an unprecedented effort to develop vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on a timescale that has never been imagined before. Even as some vaccines have begun to be administered on a large scale, scientists and governments are coming up against a difficult obstacle.

3 Dec 2020

Study evaluates the use of flow cytometry in diagnosing male urethritis

According to the World Health Organization, the global prevalence estimates of sexually transmitted infections for men in 2016 were 2.7% for chlamydia, 0.7% for gonorrhea and 0.6% for trichomoniasis. In men, these and other sexually transmitted infections may lead to urethritis, inflammation of the urethra.

3 Dec 2020

Smoking may increase some people's risk of testing positive for COVID-19

Researchers in the United States have conducted a detailed analysis examining whether smoking increases or decreases the risk of testing positive for coronavirus disease 2019 (COVID-19).

3 Dec 2020

CDC to reduce quarantine period from 14 days to 7 to 10 days

The U.S. Centers for Disease Control and Prevention (CDC), along with other health agencies such as the World Health Organization (WHO), recommend that people who may have been in close contact with a coronavirus disease (COVID-19) case should undergo quarantine for 14 days.

2 Dec 2020

UCLA, UCSF obtain FDA approval for PSMA PET imaging in men with prostate cancer

The University of California's two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.

2 Dec 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

Does smoking increase risk of COVID-19 hospitalization?

A study conducted by UK researchers has found that patients hospitalized with coronavirus disease 2019 (COVID-19) were less likely to be current smokers than patients who had been admitted with other types of respiratory viral infections last year (2019).

1 Dec 2020